MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early–stage lung cancer patients from the IFCT-0002 Phase 3 Trial

INTRODUCTION: DNA repair is a double-edged sword in lung carcinogenesis. When defective, it promotes genetic instability and accumulated genetic alterations. Conversely these defects could sensitize cancer cells to therapeutic agents inducing DNA breaks. METHODS: We used immunohistochemistry (IHC) t...

Descripción completa

Detalles Bibliográficos
Autores principales: Levallet, Guénaëlle, Dubois, Fatéméh, Fouret, Pierre, Antoine, Martine, Brosseau, Solenn, Bergot, Emmanuel, Beau-Faller, Michèle, Gounant, Valérie, Brambilla, Elisabeth, Debieuvre, Didier, Molinier, Olivier, Galateau-Sallé, Françoise, Mazieres, Julien, Quoix, Elisabeth, Pujol, Jean-Louis, Moro-Sibilot, Denis, Langlais, Alexandra, Morin, Franck, Westeel, Virginie, Zalcman, Gérard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354834/
https://www.ncbi.nlm.nih.gov/pubmed/28008145
http://dx.doi.org/10.18632/oncotarget.14025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354834/
https://www.ncbi.nlm.nih.gov/pubmed/28008145
http://dx.doi.org/10.18632/oncotarget.14025

Ejemplares similares